AIM Rule 17 Schedule 2(g) Update
30 March 2022, 12:01 UTC By inhc
30 March 2022, 12:01 UTC By inhc
Induction Healthcare Group PLC
(“Induction”, the “Company”, or the “Group”)
AIM Rule 17 Schedule 2(g) Update
Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces the following information relating to directors’ disclosure under Schedule Two, paragraph (g) of the AIM Rules for Companies:
Chris Spencer, non-executive Chairman, has been a director of a private company, Acea Health Limited, since 2 April 2018. On 29 March 2022, Acea Health Limited entered into creditors voluntary liquidation.
ENQUIRIES
| Induction
James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer |
Via Walbrook PR Ltd: induction@walbrookpr.com |
| Singer Capital Markets (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
| Philip Davies / Kailey Aliyar | |
| Walbrook PR Ltd | induction@walbrookpr.com |
| Paul McManus / Stephanie Cuthbert | Mob: +44(0)7980 541 893 / +44 (0)7796 794 663 |
About Induction – www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face – enabling a more flexible, efficient and positive experience for the communities they serve. Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.